Clinical trial
Buprenorphine Dose Alteration Study
NCT00000219 is registered in ClinicalTrials.gov with University of Vermont as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Buprenorphine Dose Alteration Study
- Lead sponsor
- University of Vermont
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- December 31, 1991
- Completion date
- July 31, 2001
- Enrollment
- 0
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.